Fundamental Analysis
74 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +13100.4% | +4632.4% | 3 / 3 | +6.5% | +5.44 pp | +10.76 pp | +21.2% | 2.42 | 5.81 | 428 | +6,5% | 46,4 | +13.100,4% | 5.81 | 37.24 | −84,4% |
| Pts | 12 | 12 | 12 | 0 | 12 | 12 | 12 | -4 | 12 | |||||||
Valuation annotation:Price: 20.000 (close price on 2026-10-15)EPS (TTM): 3.440
Financial charts
1.Revenue & growth
VND bn430Q2/26
1.Revenue & growth
VND bn430Q2/26
2.Profit & growth
VND bn46,4Q2/26
3.Profit mix (Penman)
VND bn89,7Q2/26
4.Margins & cost structure
%10.3%Q2/26
5.Returns & cash cycle
% · days6.5%Q2/26
6.Earnings quality & cash
VND bn-39,3Q2/26
7.Asset structure
VND bn2.582Q2/26
8.Funding & debt health
VND bn · times2.582Q2/26
9.Revenue backlog
VND bn96,6Q2/26
10.Valuation
times · %5,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %2.391Q2/26
Adjusted EPS growth, latest quarter
132,1× higher
Average adjusted EPS growth, 3 quarters
70,0× higher
averaged over 2 quarter(s)
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26